Blood-based biomarkers in Alzheimer disease: Current state of the science and a novel collaborative paradigm for advancing from discovery to clinic

Written By Yiran Gan

2017.02.02

S. E. O'Bryant et al., "Blood-based biomarkers in Alzheimer disease: Current state of the science and a novel collaborative paradigm for advancing from discovery to clinic" Alzheimers Dement., 13(1):45-58 (2017).

http://www.alzheimersanddementia.com/article/S1552-5260(16)33056-4/abstract

Yiran Gan
Previous

Bio-functionalized magnetic nanoparticles for the immunoassay of fetal fibronectin: a feasibility study for the prediction of preterm birth
Next

Blood Beta-Amyloid and Tau in Down Syndrome: A Comparison with Alzheimer’s Disease